Category Archives: Forensic Neuropsychiatry

Serotonin and the marketing of a depression myth

Posted on October 10, 2015 by Maurice Preter MD

Serotonin and the marketing of a depression myth Serotonin and depression BMJ 2015; 350 doi: http://dx.doi.org.ezproxy.cul.columbia.edu/10.1136/bmj.h1771 (Published 21 April 2015)Cite this as: BMJ 2015;350:h1771 Article Related content Metrics Responses David Healy, professor of psychiatry Author affiliations david.healy54@googlemail.com The marketing of a myth The serotonin reuptake inhibiting … Continue reading →

Posted in Aging, China, dietary, epigenetics, Events, Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, News, Psychiatry/Neurology | Tagged Depression, Inflammation, long-term effects, Medication effects - wanted and unwanted, suicide |

Benzodiazepine use and risk of Alzheimer’s disease

Posted on October 10, 2015 by Maurice Preter MD

Benzodiazepine use is associated with an increased risk of Alzheimer’s disease. The stronger association observed for long term exposures reinforces the suspicion of a possible direct association, even if benzodiazepine use might also be an early marker of a condition associated with an increased risk of dementia. Unwarranted long term use of these drugs should be considered as a public health concern. Continue reading →

Posted in Aging, China, Events, Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, News, Psychiatry/Neurology | Tagged Depression, healthy brain aging, informed consent, long-term effects, Medication effects - wanted and unwanted, Memory and Memory Loss |

Benzodiazepine use associated with increased risk of dementia.

Posted on October 10, 2015 by Maurice Preter MD

Conclusions In this prospective population based study, new use of benzodiazepines was associated with increased risk of dementia. The result was robust in pooled analyses across cohorts of new users of benzodiazepines throughout the study and in a complementary case-control study. Considering the extent to which benzodiazepines are prescribed and the number of potential adverse effects of this drug class in the general population, indiscriminate widespread use should be cautioned against. Continue reading →

Posted in Aging, China, Events, Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, News, Psychiatry/Neurology | Tagged healthy brain aging, informed consent, keto, long-term effects, Medication effects - wanted and unwanted, Memory and Memory Loss |

Neuroprotective and disease-modifying effects of the ketogenic diet

Posted on June 28, 2015 by Maurice Preter MD

Behav Pharmacol. 2006 Sep; 17(5-6): 431–439. PMCID: PMC2367001 NIHMSID: NIHMS42857 Neuroprotective and disease-modifying effects of the ketogenic diet Maciej Gasior,a Michael A. Rogawski,a and Adam L. Hartmana,b Author information ► Copyright and License information ► The publisher’s final edited version of this article is available at Behav Pharmacol … Continue reading →

Posted in Aging, China, dietary, epigenetics, Events, Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, News, Psychiatry/Neurology | Tagged concussions, healthy brain aging, Inflammation, informed consent, keto, Memory and Memory Loss, Parkinson disease, stroke, Traumatic Brain Injury |

Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects.

Posted on June 26, 2015 by Maurice Preter MD

Neurology. 2005 May 24;64(10):1704-11. Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Enzinger C1, Fazekas F, Matthews PM, Ropele S, Schmidt H, Smith S, Schmidt R. Author information Abstract OBJECTIVES: To determine the rate of brain atrophy in neurologically asymptomatic elderly … Continue reading →

Posted in Aging, China, dietary, epigenetics, Events, Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, News, Psychiatry/Neurology | Tagged Depression, healthy brain aging, Inflammation, keto, long-term effects |

Category Archives: Forensic Neuropsychiatry

Serotonin and the marketing of a depression myth

Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects.

Maurice Preter, MD

QUICK LINKS

ADDRESS